Opinionated, data-backed coverage across all asset classes

A new industry analysis urges insurers to replace project-based tech teams with product teams built around underwriting and claims, warning that silos begin with structure, not communication.

FDA announced a nationwide recall of nearly 40,000 Clear Eyes eye-drop bottles due to potential contamination. Consumers advised to stop use and return product.

Short sellers lost $2.74B, 92% of all liquidations. A $48.8M BTC-USD trade on Hyperliquid was the largest single position. All-time record remains $19.16B.

Finance Minister Nirmala Sitharaman announced a high-level panel on banking reforms. The Mint editorial outlines the challenges: unfinished reforms, PSB stake reduction, digital disruption, and the e-rupee.

Analysis of 2.8 billion roof observations shows temperature swings accelerate roof aging by 23%. The data suggests insurers should track property condition between storms, not just during them.

Employment fell 15,800 in July, the first drop in months, pushing the jobless rate to its highest since late 2021. Full-time roles rose; part-time drove the decline.

Fortescue's statutory net profit fell to US$2.9 billion, hit by a $525m impairment at Iron Bridge. Underlying earnings improved on higher volumes and iron ore pricing. The miner is also investing in a 2.4GW Pilbara green grid.

Japan's July exports rose 23.2%, beating consensus. Weak yen and oil prices distort the headline: volumes only +5.2%, trade deficit widens to ¥634.5bn.

ET's $5.9B capex plan includes a gas pipeline for Oracle's data center now delayed six months by state and federal certification hurdles, risking cancellation.

The 30-year Treasury yield touched 5.31% as investors absorbed $1 trillion in new debt in three months. Treasury Secretary Bessent doubled the buyback program starting September 9.

BSE, MSCI pact; LIC gets RBI nod for up to 9.99% HDFC Bank stake; Aditya Infotech to raise ₹1,500 crore; Titagarh Rail gets Railways vendor approval; Gravita adds 59,200 TPA copper recycling capacity; Ramco Systems wins Pem-Air deal; Strides Pharma gets USFDA closure letter; Ceigall India bags ₹2,423.70 crore road contracts.

MPC is up 121% in 2026 on surging refining margins and aggressive buybacks. At $285, the stock has already priced in peak-cycle earnings — the next margin report will decide the next leg.